CD16A Shedding Regulates Innate Cell Engager‐Induced Serial Killing by Natural Killer Cells
European Journal of Immunology · 2025-10 · 55 (10)
DOI: 10.1002/eji.70078 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Immunology, online erschienen am 20.10.2025. Verfasst von Chiara Zambarda und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Applied Physics, Science for Life Laboratory, KTH Royal Institute of Technology, Stockholm, Sweden. Hauptthemen laut MEDLINE: Killer Cells, Natural, Receptors, IgG, Antibody-Dependent Cell Cytotoxicity. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Natural killer (NK) cells can protect from tumor‐transformed cells using a fine‐tuned machinery of activating and inhibiting receptors. An important activating receptor is Fc gamma receptor IIIa (FcγRIIIA or CD16A), which can trigger antibody‐dependent cellular cytotoxicity (ADCC) when recognizing antibody‐opsonized target cells. One strategy to boost ADCC responses may be achieved by inhibiting activation‐induced shedding of CD16A from the NK cell surface. However, previous preclinical studies have shown contrasting results regarding the effectiveness and limitations of this approach. Here, microchip‐based live cell‐imaging was used to assess the consequences of CD16A shedding inhibition on the dynamics of NK cell cytotoxicity. The bispecific innate cell engager acimtamig (AFM13) was superior to IgG1 monoclonal antibodies in ADCC and in increasing the fraction of cytotoxic NK cells and serial killers. Under conditions where CD16A shedding was inhibited, acimtamig still triggered ADCC; however, the ability to promote serial killing was reduced and associated with impaired NK cell detachment from target cells. These results demonstrate that CD16A shedding represents an intrinsic feature of NK cell biology that is critical to sustain the antitumoral cytotoxicity of NK cells. This has implications for CD16A engineering of NK cell products and their combination with CD16A‐directed NK cell engagers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Applied Physics, Science for Life Laboratory, KTH Royal Institute of Technology, Stockholm, Sweden.
- Affimed GmbH, Mannheim, Germany.
- Department of Medicine Huddinge, Center for Infectious Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
- Department of Medicine Huddinge, Center for Hematology and Regenerative Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
Zitieren
APA
Zambarda, C., Guldevall, K., Breunig, C., Toullec, D., Sandoz, P. A., Carannante, V., Xu, S., Ross, P., Kuhnigk, K., Sandström, N., Fontana, J., Wingert, S., Pinto, S., Knoch, J., Hussain, A., Wagner, A. K., Pahl, J., Alici, E., Koch, J., & Önfelt, B. (2025). CD16A Shedding Regulates Innate Cell Engager‐Induced Serial Killing by Natural Killer Cells. European Journal of Immunology, 55(10). https://doi.org/10.1002/eji.70078
Vancouver
Zambarda C, Guldevall K, Breunig C, Toullec D, Sandoz PA, Carannante V, et al. CD16A Shedding Regulates Innate Cell Engager‐Induced Serial Killing by Natural Killer Cells. European Journal of Immunology. 2025;55(10). doi:10.1002/eji.70078
BibTeX
@article{Zambarda2025,
author = {Zambarda, Chiara and Guldevall, Karolin and Breunig, Christian and Toullec, Damien and Sandoz, Patrick A and Carannante, Valentina and Xu, Shanshan and Ross, Patrick and Kuhnigk, Kyra and Sandström, Niklas and Fontana, Jacopo and Wingert, Susanne and Pinto, Sheena and Knoch, Julia and Hussain, Alamdar and Wagner, Arnika K and Pahl, Jens and Alici, Evren and Koch, Joachim and Önfelt, Björn},
title = {CD16A Shedding Regulates Innate Cell Engager‐Induced Serial Killing by Natural Killer Cells},
journal = {European Journal of Immunology},
year = {2025},
volume = {55},
number = {10},
doi = {10.1002/eji.70078}
}
EUVIMED